GSK_ Annual_Report_2021-22

21 The Members/claimants whose shares, unclaimed dividend, etc. have been transferred to the Fund may claim the shares by making an application to IEPF Authority in Form IEPF-5 (available on www.iepf.gov.in) along with requisite fee as decided by the Authority from time to time. The Member/ claimant can file only one consolidated claim in a financial year as per the IEPF Rules and amendments thereto. 14. Action required to be taken by the members in case of non-receipt/non-encashment of dividends: In case of non-receipt/non-encashment of dividend warrants, members are requested to correspond with the Company’s Registered Office/the Registrar and Share Transfer Agent. Dividend Financial Year Dividend Declaration Date Rate of Dividend per share ( ` ) Due date for transfer to IEPF 68 Dividend 2014-2015 1/August/2015 63 5 September 2022 69 Dividend 2015-2016 29/July/2016 50 3 September 2023 70 Dividend 2016-2017 26/July/2017 30 30 August 2024 71 Dividend 2017-2018 25/July/2018 35 29 August 2025 72 Dividend 2018-2019 23/July/2019 20 27 August 2026 73 Dividend 2019-2020 27/July/2020 40 1 September 2027 74 Dividend 2020-2021 27/July/2021 30 31 August 2028 The Ministry of Corporate Affairs has undertaken a “Green Initiative in Corporate Governance” and allowed companies to share documents with its Members through the electronic mode. In compliance with the aforesaid MCA Circulars and SEBI Circular dated 12 May, 2020, 15 January, 2021 and 13 May, 2022, Notice of the AGM along with the Annual Report 2021-22 is being sent only through electronic mode to those Members whose email addresses are registered with the Company/Depositories. Members may note that the Notice and Annual Report 2021-22 will also be available on the Company’s website (https://india-pharma.gsk.com/en-in/investors/ shareholder- information), websites of the Stock Exchanges i.e. BSE Limited and National Stock Exchange of India Limited at www.bseindia.com and www.nseindia.com respectively. Members are requested to support this Green Initiative by registering/updating their e-mail addresses for receiving electronic communications. Members who wish to register their email address/ bank account mandate may follow the below instructions- Dematerialized Holding Register/update the details in your demat account, as per process advised by your Depository Participant (DP) Physical Holding Register/update the details in prescribed form ISR-1 and other relevant forms with Registrar and Transfer Agents of the Company, KFin Technologies Limited at einward@kfintech.com Member may download prescribed forms from the Company’s website at https://india-pharma.gsk.com/en-in/ investors/shareholder-information/ download- forms/ 15. The Securities and Exchange Board of India (SEBI) has mandated the submission of Permanent Account Number (PAN) by every participant in the securities market. Members holding shares in electronic form are, accordingly, requested to submit their PAN to the Depository Participants with whom they maintain their Demat accounts. Members holding shares in physical form should submit their PAN to the Company. 16. Members who have not registered / updated their email addresses with KFin Technologies, if shares are held in physical mode or with their DPs, if shares are held in electronic mode, are requested to do so for receiving all future communications from Company including Annual Reports, Notices, Circulars etc. electronically. 17. The Company has sent individual letters to all the Members holding shares of the Company in physical form for furnishing their PAN, KYC details and Nomination pursuant to SEBI Circular No. SEBI/HO/MIRSD/MIRSD_ RTAMB/P/CIR/2021/655 dated 3 November, 2021. The aforesaid communication is also intimated to the stock exchanges and available on the website of the Company. Attention of the Members holding shares of the Company in physical form are invited to go through the said important communication under the weblink at https://india-pharma. gsk.com/en-in/investors/shareholder-information/ download-forms/. Members may please note that SEBI vide its Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25 January, 2022 has mandated the Listed Companies to issue securities in demat form only while processing service requests viz. Issue of duplicate securities certificate; claim from Unclaimed Suspense Account; Renewal/Exchange of securities certificate;